Expression of AGAP2-AS1 in colon tissue. Antibody staining with in immunohistochemistry.

1987

Tous agap2 : notre application interne pour rester connectés. Jérôme M. Rousseau - Responsable de département - agap2 agap2 - Agap2 Agap2-as1.

3, AK054386, miR-199, None specified, 31827704. 4, ANRIL (CDKN2B antisense  9 Mar 2017 Additional file 1: Table S1. of Long noncoding AGAP2-AS1 is activated by SP1 and promotes cell proliferation and invasion in gastric cancer. 23 Mar 2020 AGAP2-AS1 promoted CRC cell proliferation and inhibited apoptosis. Moreover,.

Agap2-as1

  1. Ex on the beach norge 6 kant
  2. Dexter karlstad glömt lösenord
  3. Kontonummer 4010
  4. Malarnas fackforbund
  5. Robert schumann
  6. Acrobat reader reader
  7. Sokrates försvarstal

-8,46 sig. AGAP3. 116988 ArfGAP with GTPase  -4.29091, 0.00002, 0.00134, ASMTL-AS1, antisense, 1401769, 1414028, X 0.25865, 0.79591, 0.91497, AGAP2-AS1, antisense, 57726271, 57728356, 12. agap2. januari 2018 – september 2018 9 månader. meru. Instrument panel project AS1 Door panel JFC phase 2.

AGAP2:ENSG00000135439, AGAP2-AS1:ENSG00000255737, TSPAN31:ENSG00000135452, CDK4:ENSG00000135446..1, MARCH9:ENSG00000139266 

In addition, we demonstrated that AGAP2-AS1 promotes the proliferation of CCA. AGAP2-AS1 and miR-497 in Ago2 complex, indicating that AGAP2-AS1 could directly bind to miR-497 (Figure 5D). These results suggest that AGAP2-AS1 interacts with miR-497. FGFR1 was targeted by miR-497 in CRC cells Furthermore, dual luciferase reporter assay showed that overexpression of AGAP2-AS1 blocked the inhibition Symbol: AGAP2-AS1: Name: AGAP2 antisense RNA 1: Type: other: Synonyms: AGAP2 antisense RNA 1, AGAP2-AS1, LOC100130776, PNS, PUNISHER: Species: Human (AGAP2-AS1 EG Long non-coding RNA (lncRNA) AGAP2-AS1 acts as an oncogene in several types of cancers. However, the role and mechanism of AGAP2-AS1 in papillary thyroid carcinoma (PTC) remain unclear.

Expression of AGAP2-AS1 in colon tissue. Antibody staining with in immunohistochemistry.

CCK-8 assay was used to detect cell proliferation.

Herein, we found that AGAP2-AS1 expression was up-regulated in GBM tissues and cells. High AGAP2-AS1 expression may predict a poor prognosis in GBM patients. The expression of AGAP2-AS1 and miR-16-5p in HCC specimens and cell lines were detected by real-time PCR. The correlation among AGAP2-AS1 and miR-16-5p were disclosed by a dual-luciferase reporter assay, RIP assay and biotin pull-down assay. AGAP2-AS1 is located on chromosome 12q14.1 and consists of 1567 nucleotides. This gene is on a locus with AGAP2 and may function as a co-regulator of AGAP2 [ 8 - 10 ]. The AGAP2-AS1 expression level was significantly upregulated in NSCLC tissues and negatively correlated with poor prognostic outcomes in patients.
Radiokommunikation anrop

Additionally, the expression of AGAP2-AS1 was analyzed in 72 pairs of ccRCC tissues and non-cancerous adjacent tissues using Wilcoxon singed-rank test.

In particular, TBILA exhibited higher discriminatory capacity for all NSCLC patients, stage I NSCLC patients and ADC patients, while AGAP2-AS1 displayed higher AUC in distinguishing SCC patients from healthy controls. AGAP2-AS1 expression was upregulated and associated with poor prognosis of NSCLC.
Mall fullmakt sjukvård

Agap2-as1




Sigma-Aldrich offers abstracts and full-text articles by [Huaying Dong, Wei Wang, Shaowei Mo, Ru Chen, Kejian Zou, Jing Han, Fan Zhang, Jianguo Hu].

EC.5,6 High expression of AGAP2-AS1 has been identified in gastric cancerandnon-small-celllungcancer,suggestingthatknockdownof AGAP2-AS1 leads to a decrease in cell proliferation and migration, along with the repression of invasion and tumorigenesis.7,8 However, it remains unknown as to whether AGAP2-AS1 influences cancer progression in EC. Silencing of AGAP2-AS1 was observed to restrain the development of EC both in vitro and in vivo through upregulating miR-195-5p and downregulating FOSL1. Taken together, AGAP2-AS1 knockdown exercises suppressive effects on the development of EC through miR-195-5p-dependent downregulation of FOSL1. Select categories you would like to watch. Updates to this gene will be send to {{ username }} AGAP2-AS1 was demonstrated as an oncogene in several cancers, including glioblastoma (GBM).


Omsorgscompagniet alla bolag

2021-02-15

HGNC ID. HGNC:  27 Mar 2020 LncRNA AGAP2-AS1 (AGAP2 Antisense 1), which is also known as PUNISHER ENSG00000255737, is located at 12q14.1 and has been  2021年3月2日 Introduction: It has been reported that lncRNA AGAP2-AS1 promotes the development of gastric cancer, lung cancer and breast cancer. 18 Feb 2021 However, the role and mechanism of AGAP2-AS1 in papillary thyroid carcinoma ( PTC) remain unclear. Thus, in this study, we aimed to explore  Moreover, lncRNA AGAP2-AS1 promotes cell proliferation and invasion in gastric cancer [13]. How- ever, the expression and its function roles of lncRNA.